PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells

PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells

Drug resistance and metastasis are two major obstacles to cancer chemotherapy. During metastasis, cancer cells can survive as floating cells in the blood or lymphatic circulatory system, due to the acquisition of resistance to anoikis—a programmed cell death activated by loss of extracellular matrix...

Full description

Bibliographic Details
Main Authors: Sasivimon Pramual, Kriengsak Lirdprapamongkol, Korakot Atjanasuppat, Papada Chaisuriya, Nuttawee Niamsiri, Jisnuson Svasti
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Molecules
Subjects:
PLA-based materials
nanoparticles
drug delivery
paclitaxel resistance
metastasis
lung cancer
Online Access:https://www.mdpi.com/1420-3049/27/23/8295

Internet

https://www.mdpi.com/1420-3049/27/23/8295

Similar Items